Home > Annual Financials > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS Financial Statement Analysis
[BOM: 500420|NSE : TORNTPHARM]

The Revenues of TORRENT PHARMACEUTICALS have increased by 13.07% YoY .
The Earnings Per Share (EPS) of TORRENT PHARMACEUTICALS has increased by 33.03 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

TORRENT PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 500420|NSE : TORNTPHARM]

ConsolidatedMar2024
Mar2023
Mar2022
Mar2021
Mar2020
Revenues ₹9,620 Cr₹8,508 Cr₹8,005 Cr₹7,939 Cr₹7,673 Cr
Expenses ₹6,796 Cr₹6,077 Cr₹5,524 Cr₹5,769 Cr₹5,696 Cr
Operating Profit (Excl OI) ₹2,824 Cr₹2,431 Cr₹2,480 Cr₹2,170 Cr₹1,976 Cr
Other Income ₹63 Cr₹197 Cr₹57 Cr₹121 Cr₹64 Cr
Interest ₹333 Cr₹255 Cr₹353 Cr₹451 Cr₹504 Cr
Depreciation ₹707 Cr₹662 Cr₹658 Cr₹654 Cr₹618 Cr
Profit Before Tax ₹1,847 Cr₹1,226 Cr₹1,526 Cr₹1,187 Cr₹562 Cr
Profit After Tax ₹1,245 Cr₹777 Cr₹1,252 Cr₹1,025 Cr₹436 Cr
Consolidated Net Profit ₹1,245 Cr₹777 Cr₹1,252 Cr₹1,025 Cr₹436 Cr
Earnings Per Share (Rs)₹48.94₹36.79₹45.92₹73.97₹60.55
PAT Margin (%)9.927.635.118.416.85
ROE(%)25.3820.5013.1823.4921.47
ROCE(%)24.2820.3214.3517.6215.28
Total Debt/Equity(x)0.570.850.680.831.21

Key Financials

Market Cap : ₹ 104,127.4 Cr
Revenue (TTM) : ₹ 11,302.0 Cr
Net Profit(TTM) : ₹ 1,862.0 Cr
EPS (TTM) : ₹ 55.0
P/E (TTM) : 55.9

Industry Peers & Returns1W1M1Y
TORRENT PHARMACEUTICALS -0.9% -2.8% 16.8%
SUN PHARMACEUTICAL INDUSTRIES 0.8% -3.5% 12.9%
CIPLA 1.4% 1.9% 2.5%
DR REDDYS LABORATORIES -1% -7.9% -4.4%
ZYDUS LIFESCIENCES -1.9% -7.1% 2.5%
DIVIS LABORATORIES -0.5% -1.3% 57.3%
MANKIND PHARMA -4.3% -13.3% 8.5%
LUPIN -2% -5% 22.6%
AUROBINDO PHARMA 2% -2.7% 11%


TORRENT PHARMACEUTICALS Revenues
[BOM: 500420|NSE : TORNTPHARM]

Y-o-Y

13.07 %

5 Yr CAGR

5.82 %

Years Revenues % Change
Mar2024 ₹9,620 Cr
13.07
Mar2023 ₹8,508 Cr
6.29
Mar2022 ₹8,005 Cr
0.82
Mar2021 ₹7,939 Cr
3.47
Mar2020 ₹7,673 Cr -


TORRENT PHARMACEUTICALS Operating Profit
[BOM: 500420|NSE : TORNTPHARM]

Y-o-Y

16.15 %

5 Yr CAGR

9.33 %

Years Operating Profit % Change
Mar2024 ₹2,824 Cr
16.15
Mar2023 ₹2,431 Cr
-1.97
Mar2022 ₹2,480 Cr
14.27
Mar2021 ₹2,170 Cr
9.81
Mar2020 ₹1,976 Cr -

Operating Margins
Y-o-Y

2.69 %

5 Yr CAGR

3.32 %

Years Operating Margin% % Change
Mar2024 29.35%
2.69
Mar2023 28.58%
-7.75
Mar2022 30.98%
13.31
Mar2021 27.34%
6.13
Mar2020 25.76% -

TORRENT PHARMACEUTICALS Profit After Tax
[BOM: 500420|NSE : TORNTPHARM]

Y-o-Y

60.22 %

5 Yr CAGR

29.98 %

Years Profit After Tax % Change
Mar2024 ₹1,245 Cr
60.22
Mar2023 ₹777 Cr
-37.92
Mar2022 ₹1,252 Cr
22.17
Mar2021 ₹1,025 Cr
134.88
Mar2020 ₹436 Cr -

PAT Margins
Y-o-Y

30.01 %

5 Yr CAGR

9.70 %

Years PAT Margin(%) % Change
Mar2024 9.92 %
30.01
Mar2023 7.63 %
49.32
Mar2022 5.11 %
-39.24
Mar2021 8.41 %
22.77
Mar2020 6.85 % -

TORRENT PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 500420|NSE : TORNTPHARM]

Y-o-Y

33.03 %

5 Yr CAGR

-5.18 %

Years EPS % Change
Mar2024 ₹49
33.03
Mar2023 ₹37
-19.88
Mar2022 ₹46
-37.92
Mar2021 ₹74
22.16
Mar2020 ₹61 -

TORRENT PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 500420|NSE : TORNTPHARM]

Y-o-Y

19.49 %

5 Yr CAGR

12.27 %

Years ROCE % Change
Mar2024 24.28%
19.49
Mar2023 20.32%
41.60
Mar2022 14.35%
-18.56
Mar2021 17.62%
15.31
Mar2020 15.28% -

TORRENT PHARMACEUTICALS Share Price vs Sensex

Current Share Price : ₹3,077.1
Current MarketCap: ₹ 104,127.4 Cr
Updated EOD on :Feb 17,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-0.9%

-2.8%

16.8%

SENSEX

-1.7%

-0.8%

5.8%

TORRENT PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
S&P BSE 100 LARGECAP TMC -2.3% -2.5% 3.9%
S&P BSE QUALITY -2.7% -6% -1.2%
S&P BSE 200 -2.7% -3.4% 4.2%
S&P BSE LARGE MIDCAP -2.8% -3.6% 3.5%
S&P BSE 250 LARGEMIDCAP -2.8% -3.7% 3.9%
NSE Indices1W1M1Y
NIFTY100 LOW VOLATILITY 30 -1.5% -0.8% 5.3%
NIFTY 100 -2.3% -2.4% 4.6%
NIFTY PHARMA -2.7% -4.5% 13.4%
NIFTY 200 -2.8% -3.5% 4.3%
NIFTY HEALTHCARE -3% -4% 12.9%

You may also like the below Video Courses


FAQ about TORRENT PHARMACEUTICALS Financials


How the annual revenues of TORRENT PHARMACEUTICALS have changed ?

The Revenues of TORRENT PHARMACEUTICALS have increased by 13.07% YoY .

How the Earnings per Share (EPS) of TORRENT PHARMACEUTICALS have changed?

The Earnings Per Share (EPS) of TORRENT PHARMACEUTICALS has increased by 33.03 % YoY .